2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 211.584 | 200.585 | 239.610 | 239.670 | 281.030 | 308.014 | 238.885 | 252.409 | 309.814 | 300.023 |
Total Income - EUR | 211.622 | 200.585 | 246.023 | 239.890 | 281.261 | 308.014 | 238.885 | 252.409 | 309.814 | 300.023 |
Total Expenses - EUR | 198.775 | 180.022 | 221.895 | 213.515 | 232.206 | 246.325 | 190.337 | 188.568 | 206.418 | 188.124 |
Gross Profit/Loss - EUR | 12.847 | 20.563 | 24.129 | 26.375 | 49.055 | 61.689 | 48.549 | 63.842 | 103.396 | 111.899 |
Net Profit/Loss - EUR | 10.784 | 17.273 | 20.265 | 23.592 | 46.243 | 58.609 | 46.338 | 61.318 | 100.743 | 108.899 |
Employees | 7 | 6 | 6 | 7 | 7 | 8 | 7 | 6 | 5 | 4 |
Check the financial reports for the company - Endo Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 6.426 | 1.948 | 938 | 20.836 | 15.358 | 10.818 | 6.007 | 901 | 0 | 0 |
Current Assets | 38.445 | 36.575 | 50.113 | 47.111 | 56.010 | 75.949 | 69.090 | 87.339 | 142.521 | 147.701 |
Inventories | 4.347 | 2.850 | 5.304 | 6.706 | 6.815 | 12.038 | 6.596 | 8.003 | 20.064 | 8.200 |
Receivables | 28.385 | 21.255 | 38.946 | 36.242 | 33.144 | 28.793 | 34.443 | 36.077 | 88.177 | 136.670 |
Cash | 5.714 | 12.470 | 5.862 | 4.164 | 16.051 | 35.118 | 28.051 | 43.259 | 34.279 | 2.831 |
Shareholders Funds | 18.036 | 24.586 | 27.502 | 30.707 | 53.227 | 65.459 | 53.057 | 67.888 | 107.334 | 115.471 |
Social Capital | 47 | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 |
Debts | 26.835 | 13.937 | 23.549 | 37.240 | 18.141 | 21.309 | 22.040 | 20.352 | 35.187 | 32.231 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1721 - 1721" | |||||||||
CAEN Financial Year |
1721
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Endo Srl